Stefano Gianoli, PhD

Leveraging advanced immunology and AI-driven insights to de-risk early-stage biotech assets. Specialized in Scientific Due Diligence, Market Sizing, and Strategic Advisory for high-impact therapeutic areas. Bridging the gap between Harvard-led research and the Boston venture capital and consulting ecosystem. Key Achievements: - Search & Evaluation | Asset De-risking: Directed the technical validation of a novel pharmacological target for acute lung injury. Performed Competitive Landscape Analysis for a therapeutic market projected at $4.3B (2035), aligning scientific milestones with investment viability. - Operational Strategy & Cost Modeling: Engineered a clinical workflow optimization model that reduced projected ICU stays by 30%. Modeled an estimated $15K in savings per patient, demonstrating the ROI of translational process improvements. - Strategic Grant Development: Key contributor to the development of an NIH R21 exploratory grant; synthesized complex biological data into high-level strategic proposals focused on therapeutic feasibility and clinical scalability. - Strategic Advisory & Stakeholder Engagement: Acted as a technical consultant for department leadership, delivering biweekly briefs to senior stakeholders. Brokered 2 new external collaborations by identifying strategic synergies between academic research and industry needs. - Project Leadership (Management Consulting Frameworks): Led a cross-functional team of 3 researchers, applying efficiency frameworks that boosted lab productivity by 43%. Managed timelines, quality compliance, and resource allocation under high-pressure deadlines. Conclusion: I am translating complex immunological research into high-impact business assets by combining technical due diligence with strategic market analysis to drive pipeline growth and operational ROI.

Orchestrating the joint MIT-Harvard Case Competition, a premier strategic event that bridges the gap between top-tier academic talent and real-world corporate challenges. Responsible for managing the end-to-end lifecycle of the competition, from corporate partner sourcing to cross-institutional project execution. Key Achievements: - Strategic Partnership & Sourcing: Liaising with corporate sponsors to define high-stakes business challenges and securing sponsorship for prize funding, ensuring a direct link between industry needs and candidate solutions. - Project Operations & Lifecycle Management: Co-managing the competitive framework for multidisciplinary teams, overseeing a 3-week intensive sprint where teams develop actionable strategies for real-world corporate entities. - Cross-Functional Strategy: Contributing to the broader club roadmap by participating in Professional Development, Outreach, and Networking committees, ensuring operational synergy and long-term organizational growth. - Stakeholder Engagement: Facilitating high-level communication between the MIT and Harvard Graduate Consulting Clubs (HGCC), managing institutional relations to deliver a seamless, elite-level competitive experience. Conclusion: Translating organizational leadership into high-impact strategic events, fostering a competitive ecosystem where real-world business problems meet elite-tier analytical talent.

Strategic lead for ecosystem development and community engagement at Boston Children’s Hospital (Harvard Medical School affiliate). Managing operations, budgets, and high-level partnerships to accelerate career development and industry connectivity for a community of 250+ PhDs and MDs. Key Achievements: - Budget Management & Resource Allocation: Directed a $30K annual budget (P&L responsibility), optimizing resource allocation for 10+ high-impact networking and professional development programs. - Operational Leadership & Scaling: Led a cross-functional team of 8 professionals to execute complex event strategies, achieving a 50% increase in engagement (turnout grew from 40 to 60+ attendees per event) through data-driven outreach. - Executive Stakeholder Engagement: Present quarterly outcomes and strategic roadmaps to BCH Executive Leadership. Successfully secured endorsement and additional resources to scale pilot programs into permanent institutional offerings. - Strategic Partnerships & Ecosystem Building: Acted as the primary liaison between the postdoc community and industry partners, fostering collaborations that expanded the professional network and "career-readiness" of the organization. Conclusion: I contributed to driving organizational growth and operational efficiency by bridging the gap between academic excellence and industry-standard networking and leadership.

Selected through a highly competitive recruitment process to provide strategic advisory for a NYC-based health & wellness client. Leveraged structured problem-solving and hypothesis-driven frameworks to address complex growth challenges, focusing on market re-entry and service portfolio expansion to drive measurable revenue growth and operational efficiency. Key Achievements: - Market Re-entry Strategy & Revenue Growth: Engineered a comprehensive re-entry plan that expanded core services and revitalized brand positioning. Projected to secure 200+ new memberships and an estimated $200K in additional annual revenue within 12 months. - Service Portfolio Optimization: Designed and implemented a mental health service integration plan, expanding the client’s offerings from 5 to 7 (+40% growth) and enabling access for ~200 new clients in the first year. - Competitive Intelligence & Brand Positioning: Conducted a deep-dive competitor analysis to differentiate the client in the high-saturation NYC market, launching a social impact program that enhanced brand equity. - Team Leadership & Agile Execution: Led the synthesis of market and operational insights for a 4-person team. Streamlined internal workflows to deliver final recommendations 2 weeks ahead of schedule (16% faster than plan). Conclusion: I delivered actionable, data-driven solutions that translated market white spaces into concrete growth opportunities and enhanced organizational ROI.

Focused on the intersection of immunological innovation and Intellectual Property (IP). Managed multi-year research initiatives from capital acquisition to patent-ready findings, while leading organizational strategy as Student Committee Chair within a world-class research hospital. Key Achievements: - Intellectual Property (IP) Development: Spearheaded research that led to 1 patent contribution, translating complex biological discoveries into protected commercial assets and demonstrating a deep understanding of the IP landscape. - Capital Acquisition & Grant Management: Instrumental in securing a $250K research grant. Developed data-driven proposals and presented scientific milestones to funding bodies, proving the ability to attract and manage significant investment. - Organizational Leadership (Chair): Elected Chair of the Student Committee (representing 50+ researchers). Managed internal stakeholder relations, organizational budgets, and strategic initiatives to improve institutional research standards. - Team Management & Mentorship: Supervised and mentored 2 MSc students (12+ hrs/week), optimizing laboratory workflows and ensuring the delivery of high-quality data for top-tier publications (Top 5-10% journals). - Competitive Excellence: Ranked 2nd among 70+ candidates for the PhD fellowship and received multiple international travel awards (top 1% of participants), reflecting a consistent track record of high performance. Conclusion: I synthesized rigorous scientific investigation with a focus on asset creation, leadership, and funding strategy, building a foundation for strategic assessment and value-driven decision-making in the Life Sciences sector.

Managed and delivered high-impact educational programs for university cohorts, focusing on complex concept synthesis, public speaking, and strategic mentoring. Key Achievements: - Strategic Communication: Delivered lectures and training modules to large audiences (200+ students), mastering the ability to translate technical concepts into accessible, actionable insights. - Program Coordination: Managed the administrative and operational logistics of the OFA program for 4 consecutive years, ensuring high standards of delivery and student retention. - Mentoring & Leadership: Acted as a primary mentor for incoming students, facilitating their integration into the university ecosystem through structured feedback and coaching. Conclusion: I developed elite communication and organizational skills, essential for stakeholder engagement and the presentation of complex value propositions in corporate and clinical settings.

Summary: Accelerated cardiovascular translational research by integrating bio-engineering and pharmacology. Supported senior leadership in project execution, focusing on 3D modeling to optimize drug validation timelines and R&D efficiency. Key Achievements: - R&D Process Optimization: Developed 3D organoid models that reduced reliance on in vivo testing by 50%, streamlining preclinical evaluation and reducing project operational costs. - Technical Due Diligence Support: Optimized in vitro models that provided the critical data needed to secure €150,000 in laboratory grant funding. - Cross-functional Collaboration: Acted as the technical bridge within a multidisciplinary team (surgeons, engineers, and chemists), facilitating the translation of clinical graft failure data into engineering solutions. - Asset Repurposing: Executed validation studies for FDA-approved drugs targeting new cardiovascular pathways, demonstrating an early focus on therapeutic asset expansion. Conclusion: I combined rigorous technical execution with a focus on operational efficiency, contributing to significant cost reductions and successful funding rounds in a high-stakes MedTech environment.

Conducted foundational translational research on vascular graft failure, focusing on the identification of novel molecular targets to improve long-term clinical outcomes in cardiovascular surgery. Key Achievements: - Target Identification & Validation: Investigated mechanosensing pathways in human saphenous veins, identifying a novel therapeutic target (YAP signaling) to prevent graft disease. - Human-Centric Modeling: Developed and optimized ex vivo models using human patient samples, bridging the gap between molecular biology and clinical vascular surgery. - Analytical Excellence: Applied high-resolution imaging and molecular analysis to map progenitor cell behavior, providing the "proof-of-concept" data that led to a subsequent 1-year professional research extension. Conclusion: I synthesized complex biomechanical data into a potential therapeutic strategy, setting the stage for subsequent R&D optimization and funding success.

Developed a high-performance analytical platform for lipid biomarker identification, focusing on early-stage diagnostics for neurodegenerative diseases (Alzheimer's). Key Achievements: - Methodological Innovation: Integrated High-Performance Thin Layer Chromatography (HPTLC) with MALDI Mass Spectrometry to create a reliable and reproducible serum profiling workflow. - Biomarker Discovery: Identified specific fluctuations in Sphingolipids and Phospholipids, highlighting their potential as critical biomarkers for lipid dysregulation-related pathologies. - Analytical Rigor: Optimized a new methodological process for automatic sera identification, establishing early expertise in complex data analysis and molecular proteomics. Conclusion: I established foundational expertise in molecular diagnostics and biomarker discovery, initiating a career-long focus on translating complex biological data into clinical insights.

A 3-years project in the exciting field of experimental immunology, with a focus on the master cell of the inflammation, the macrophage.

I chose the "Experimental immunology and transplantations" curriculum, with an experimental thesis embedded in the cardiovascular tissue engineering field.

3 years of robust study in the red biotech field. Special interest in human immunology and cancer immunology.